CG
CSCI

Cutler Group’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Cutler Group’s Portfolio CSCI Stock Details CSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-842
Closed -$9K – 6495
2021
Q1 		$9K Buy
+842
New +$93.3K ﹤0.01% 3929
2019
Q1 		– Sell
-37
Closed -$2K – 4886
2018
Q4 		$2K Buy
+37
New +$8.84K ﹤0.01% 3472
2017
Q2 		– Sell
-145
Closed -$9K – 7220
2017
Q1 		$9K Buy
+145
New +$42.7K ﹤0.01% 4188

Other funds holding CSCI

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Cutler Group's CSCI Position: Q4 2022 in Review

Cutler Group sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q4 2022, closing a stake of 57 shares.

Cutler Group first reported a position in CSCI in Q3 2016 and held it in 24 quarters. The position peaked at $69K in Q4 2016. 13 funds tracked by Wall St. Rank hold CSCI as of Q4 2022.

  • Cutler Group reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Cutler Group sold 57 COSCIENS Biopharma Inc. Common Stock shares in Q4 2022.
  • Cutler Group first reported a position in COSCIENS Biopharma Inc. Common Stock in Q3 2016 and held it in 24 quarters.
  • Cutler Group's COSCIENS Biopharma Inc. Common Stock position peaked at $69K in Q4 2016.
  • 13 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q4 2022.

Based on Cutler Group's 13F filing for Q4 2022, filed 7 Feb 2023.